Deykin Aaron has filed 4 insider transactions across 1 company since February 2025.
Most recent transaction: a sale of 894 shares of Upstream Bio, Inc. ($UPB) on March 16, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 16, 2026 | Upstream Bio, Inc. | $UPB | Deykin Aaron | Chief Medical Officer | S | Common Stock | 894 | $9.29 | 32,687.0000 | 54,038,591 | 2.66% | 0.00% |
| Jan. 2, 2026 | Upstream Bio, Inc. | $UPB | Deykin Aaron | Chief Medical Officer | A | Common Stock | 32000 | $0.00 | 33,581.0000 | 54,038,591 | 2024.04% | 0.06% |
| Jan. 2, 2026 | Upstream Bio, Inc. | $UPB | Deykin Aaron | Chief Medical Officer | A | Stock Option (Right to Buy) | 96000 | $0.00 | 96,000.0000 | 54,038,591 | 9999.99% | 0.18% |
| Feb. 6, 2025 | Upstream Bio, Inc. | $UPB | Deykin Aaron | Chief Medical Officer | A | Stock Option (Right to Buy) | 165000 | $0.00 | 165,000.0000 | 0 | 9999.99% | 0.00% |